Microsoft’s MAI-DxO coordinates multiple AI agents to work through a diagnosis more like a consultation: asking questions, requesting tests and weighing possible explanations. In a study published in Science on October 22, 2026, it scored 83.2% on complex teaching cases, compared with 36.1% for individual generalist physicians who could use reference materials. But the headline gap needs context: GPT-5 alone scored 78.9%, and the study does not establish how MAI-DxO performs in routine patient care.
3
5
7
How MAI-DxO approaches a diagnosis
Rather than relying on one immediate answer, MAI-DxO orchestrates several AI agents that simulate parts of a medical consultation. They can ask follow-up questions, order tests and discuss possible diagnoses before settling on an answer.
4
5
That process was tested on case materials, not through decisions made while treating patients. The distinction matters: a benchmark can measure whether a system reaches a case’s recorded diagnosis, but it does not by itself show how the system would perform amid the complexity of clinical care.
5
The accuracy results—and the GPT-5 baseline
On 304 complex New England Journal of Medicine teaching cases, MAI-DxO reached 83.2% accuracy. Generalist physicians working individually scored 36.1% with reference materials; Microsoft also reported a 22.3% score for physicians without them.
1
5
7
On a separate set of 325 emergency admissions, the GPT-5-powered system scored 80.3%, compared with 46.8% for physicians.
5
7 The emergency result is another simulated benchmark, not a clinical trial showing better patient outcomes.
The model baseline helps explain what the headline comparison does—and doesn’t—tell us about the orchestration. GPT-5 with a short basic prompt scored 78.9% on the complex cases. Compared with MAI-DxO’s 83.2%, that is a 4.3-percentage-point difference, rather than the full gap between the AI system and the physicians.
3
7
One secondary account also reports estimated per-case costs of $8,409 for the GPT-5 baseline and $5,430 for MAI-DxO. These are estimates, not evidence of actual savings in clinical practice.
7
What the study cannot establish
The physician comparison involved individual generalists, not specialist teams, and the benchmark was controlled and text-only. Its findings therefore don’t establish that MAI-DxO is superior to doctors in real-world care, or that it can replace clinicians.
5
The results are best read as evidence that an orchestrated AI system performed strongly on specific diagnostic benchmarks. They do not establish its effectiveness with real patients or show whether using it improves care. Microsoft’s description of this work as progress toward “medical superintelligence” is an ambition, not a result demonstrated by these tests.
9
10